APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

Conditions:   Neuroblastoma;   Solid Tumor Interventions:   Drug: APG-115;   Drug: APG-2575 Sponsors:   Ascentage Pharma Group Inc.;   Suzhou Yasheng Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials